News

We are pleased to share our new article written in collaboration with the Hospices Civils de Lyon:

Cancer incidence and prevalence in cystic fibrosis patients with and without a lung transplant in France,

published in Frontiers in Public Health.

PELyon is happy to share its new article:

Healthcare resource use and associated costs in patients receiving pirfenidone or nintedanib for idiopathic pulmonary fibrosis,

published in Respiratory Medecine and Research.

Great thanks to the co-authors, to the CNAM for the access to SNDS data and to F. Hoffmann-La Roche company for its trust.

PELyon has been chosen to join the partners committee of  the Filière Intelligence Artificielle & Cancers.

We are proud to be part of this great initiative.